Table 4. Insights obtained for the design of AK inhibitors.
S. | Inhibitor Class | ||||
No. | Feature | Type I | Type I1/2 | Type II | Type III |
1. | Binding | DFG-in, | DFG-in, | DFG-out, | DFG-out, |
Conformation | αC-helix in, | αC-helix in, | αC-helix out, | αC-helix out, | |
A-loop in | A-loop in | A-loop out | A-loop out | ||
2. | Binding Pocket | AP, SP | BP, AP, RP, PP | AP, RP, PP, HPII | PP, HPII |
3. | Interacting Motifs | Hinge | Hinge, | Hinge, | DFG-loop, |
DFG-loop | DFG-loop, | A-loop, | |||
αC-helix, | G-loop | ||||
A-loop, | |||||
G-loop | |||||
4. | Interacting | GK+1, GK+2, | GK, GK+2, | GK+2, GK+3, | A, D, F, W, H, F |
Residues | GK+3, GK+4, | GK+3, GK+4, A, | GK+4, GK+6, K, E, | ||
GK+6 | D | A, D, F, W, H, F | |||
5. | Interactions | H-bond | H-bond | H-bond, cation-π, | H-bond, cation-π, |
π-π, CH-π | π-π, CH-π | ||||
6. | Hot-spots | 2+3 | 1+2+6 | 2+3+4+5+6+7 | 5+6+7 |
7. | Pharmacophore | HD1, HA2, HD2, | HA1, HD1, HA2, | HD1, HA2, HD2, Ar1, | HD4, HA3, Ar2 |
features | HD3, Ar1 | HD2, Ar1, L, HD4, | L, HD4, HA3, Ar2 | ||
HA3 | |||||
8. | Set | B-C | A⋃B | B⋃C | C |